Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.00, $0.29 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $123.6 million versus the consensus estimate of $143.5 million.

GUIDANCE:

Core Laboratories sees Q2 2025 revenue of $128-134 million, versus the consensus of $128.9 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.